Cell-Based Assay

Advancing Myasthenia Gravis Diagnosis: The Superior Accuracy of Cell-Based Assays in Antibody Detection

The ADAM study reveals that live and fixed cell-based assays outperform ELISA in detecting AChR and MuSK antibodies, offering enhanced diagnostic accuracy for myasthenia gravis, particularly in ocular cases.